Skip to content

50/50% Tilt and Tuned Defibrillation Waveform

50/50% Tilt and Tune Defibrillation Waveforms Utilizing High Voltage Lead Integrity Check Impedance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01325922
Enrollment
Unknown
Registered
2011-03-30
Start date
2005-01-31
Completion date
2005-11-30
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DFT Testing

Brief summary

Study Description The purpose of this study is to compare the defibrillation efficacy between the 50/50% tilt biphasic waveform and the Tuned biphasic waveform utilizing High Voltage Lead Integrity Check (HVLIC) impedance. Hypothesis The Tuned waveform reduces defibrillation thresholds (DFTs) when compared to the 50/50% tilt waveform. Study Methods * This is an acute, paired-sample, randomized (waveform testing sequence) study * Patients are implanted with an Food and Drug Administration (FDA) approved St. Jude Medical (SJM) EpicTM+ DR/VR Implantable Cardioverter Defibrillator (or any other standard output ICD after Epic+) and defibrillation lead system. * All study testing is completed at implant. * Patients are randomized to begin DFT testing with either the 50/50% tilt or Tuned waveform. * The HVLIC feature is used to measure the high voltage lead impedance and to program the Tuned and 50/50% tilt waveform pulse widths. * The DFT is determined by an optimized binary search method that is designed to reduce the overall number of VF inductions to an average of 5.13 while maintaining very high resolution and accuracy. * Total # of centers - 15 centers * Sample size - 60 patients

Interventions

PROCEDUREDFT Testing with a 50/50% tilt

Sponsors

Abbott Medical Devices
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patient is a candidate for ICD implantation. * Patient is able to tolerate DFT testing.

Exclusion criteria

* Patient has a mechanical valve in the tricuspid position. * Patient is pregnant. * Patient is less than 18 years old.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026